Immix Biopharma

Los Angeles, United States

Immix Biopharma is a biotech company that develops treatments for cancer and other inflammation-driven diseases.

$150.0M raised

May 2026

Post-IPO Equity

Biotechnology

Top Investors

Mesa Verde Venture Partners GOOSE Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Immix Biopharma

How much funding has Immix Biopharma raised?

Immix Biopharma has raised $150.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.

Who are Immix Biopharma's investors?

Immix Biopharma's investors include Mesa Verde Venture Partners, GOOSE Capital.

Where is Immix Biopharma headquartered?

Immix Biopharma is headquartered in Los Angeles, United States.

What does Immix Biopharma do?

Immix Biopharma is a biotech company that develops treatments for cancer and other inflammation-driven diseases.

What stage is Immix Biopharma at?

Immix Biopharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 21, 2026.

MLA

"Immix Biopharma — Funding & Investors." VCBacked, May 21, 2026, https://www.vcbacked.co/company/immix-biopharma. Accessed July 3, 2026.

APA

VCBacked. (2026). Immix Biopharma — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/immix-biopharma

Wikipedia (cite web)

{{cite web |title=Immix Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/immix-biopharma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 21, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K